8-K: Kimberly-Clark Reports Strong 2023 Results and Issues Positive 2024 Outlook

Kimberly-Clark exceeded expectations in 2023 with strong organic sales growth and improved cost recovery, and anticipates continued momentum into 2024.

Summary

• Kimberly-Clark reported full-year 2023 net sales of $20.4 billion, a 1% increase compared to the previous year.
• Organic sales grew by 5%, driven by a 6% increase in price and a 1% favorable product mix, partially offset by a 2% decrease in volume.
• The company's gross margin improved by 360 basis points to 34.4% for the full year.
• Adjusted earnings per share for 2023 were $6.57, compared to $5.63 in 2022, a 17% increase.
• Fourth-quarter sales were $5.0 billion, in line with the prior year, with organic sales up 3%.
• The company expects low-to-mid single-digit organic sales growth in 2024, with adjusted operating profit and earnings per share growing at a high single-digit to low double-digit rate on a constant-currency basis.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong organic sales growth, improved margins, and a positive outlook for 2024. While there are some negative impacts from currency and divestitures, the overall tone is optimistic and confident.

Positives

• Organic sales growth of 5% for the full year exceeded the initial outlook of 2-4%.
• Gross margin improved significantly by 360 basis points for the full year.
• Adjusted earnings per share increased by 17% year-over-year.
• The company's FORCE program generated $325 million in cost savings.
• The company returned $1.8 billion to shareholders through dividends and share repurchases.
• The company expects continued growth in 2024 with a positive outlook for organic sales, operating profit, and earnings per share.
• The company's strategic foundation and financial position have advanced.

Negatives

• Full-year operating profit decreased by 13% to $2.34 billion, although adjusted operating profit increased.
• Net sales were negatively impacted by foreign currency exchange rates and the divestiture of the tissue and K-C Professional business in Brazil.
• Fourth-quarter operating profit decreased by 6%, driven by currency impacts.
• Diluted earnings per share decreased by 9% for the full year.
• Fourth-quarter adjusted earnings per share decreased by 2%.

Risks

• The company's 2024 outlook is subject to change given the macro environment.
• Currency translation is expected to negatively impact reported net sales, operating profit, and earnings per share in 2024.
• The company faces risks related to fluctuations in foreign currency exchange rates, raw material prices, and supply chain disruptions.
• The war in Ukraine and other geopolitical events could impact the company's operations and financial results.
• Competitive pressures on selling prices could affect the company's performance.

Future Outlook

The company expects low-to-mid single-digit organic sales growth in 2024, with adjusted operating profit and earnings per share growing at a high single-digit to low double-digit rate on a constant-currency basis. Reported growth in operating profit and earnings per share are expected to be negatively impacted by approximately 400 basis points from currency translation.

Management Comments

• We had a solid finish to 2023, delivering strong organic growth as well as cost and earnings recovery above our initial expectations, said Kimberly-Clark Chairman and CEO Mike Hsu.
• We enter 2024 having advanced the Company's strategic foundation and financial position, and with confidence this phase of cost recovery and supply chain stabilization is largely behind us, said Mike Hsu.
• Moving forward, we will continue to invest in differentiating our brands and enhancing our capabilities while we maintain a disciplined cost structure in our next phase of growth, said Mike Hsu.
• Im confident we are positioned to accelerate and enhance the performance of our business and create meaningful shareholder value as we deliver our purpose of better care for a better world, said Mike Hsu.

Industry Context

Kimberly-Clark's results reflect a broader trend of consumer goods companies focusing on cost management and pricing strategies to navigate inflationary pressures and supply chain challenges. The company's emphasis on innovation and brand differentiation aligns with industry best practices for maintaining market share and driving growth.

Comparison to Industry Standards

• Procter & Gamble (PG), a major competitor, also reported strong organic sales growth in its recent earnings, indicating a similar trend in the consumer goods sector.
• Colgate-Palmolive (CL) has also focused on pricing and cost management, similar to Kimberly-Clark's FORCE program, to improve profitability.
• Kimberly-Clark's 5% organic sales growth is comparable to the performance of other large consumer staples companies, but the company's focus on cost recovery and margin improvement is a key differentiator.
• The company's 2024 outlook for high single-digit to low double-digit adjusted operating profit growth is ambitious and suggests confidence in its strategic initiatives.

Stakeholder Impact

• Shareholders will benefit from the increased earnings per share and the company's commitment to returning capital through dividends and share repurchases.
• Employees may benefit from the company's improved financial performance and strategic investments.
• Customers may benefit from the company's focus on innovation and enhancing the value proposition of its brands.
• Suppliers may be impacted by the company's cost management initiatives.

Next Steps

• The company plans to host an Investor Day in late March to detail its strategic priorities and key initiatives.
• The company will continue to focus on differentiating its brands and enhancing its capabilities while maintaining a disciplined cost structure.

Key Dates

Keywords

Kimberly-Clark, KMB, organic sales, gross margin, earnings per share, cost savings, FORCE program, 2024 outlook, personal care, consumer tissue, K-C Professional